Ugur Sahin is the founder of BioNTech.de. BioNTech.de has raised $595M in total funding. Latest round: Series B.
Ugur Sahin is the Co-Founder and CEO of BioNTech. He co-founded the company in 2008. He emphasized that the Series A and Series B financing rounds are important milestones for the company's global expansion and continued advancement of its therapeutics pipeline, focusing on individualized immunotherapies for cancer.
Full founder directory · Investor directory · Company funding database · Fundraising library